CA2347069A1 - Proteine pour le traitement ou la prevention d'un trouble de la voie gastro-intestinale - Google Patents

Proteine pour le traitement ou la prevention d'un trouble de la voie gastro-intestinale Download PDF

Info

Publication number
CA2347069A1
CA2347069A1 CA002347069A CA2347069A CA2347069A1 CA 2347069 A1 CA2347069 A1 CA 2347069A1 CA 002347069 A CA002347069 A CA 002347069A CA 2347069 A CA2347069 A CA 2347069A CA 2347069 A1 CA2347069 A1 CA 2347069A1
Authority
CA
Canada
Prior art keywords
protein
milk
serum
composition
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002347069A
Other languages
English (en)
Inventor
Karine Vidal
Anne Donnet
Eduardo Schiffrin
Mario Labeta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2347069A1 publication Critical patent/CA2347069A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne une nouvelle protéine isolée exempte de O-glycosylation et présentant au moins 70 % d'homologie avec la séquence d'acide aminé du sérum humain CD14. Par ailleurs, cette invention comprend d'une part une composition renfermant une quantité efficace de la protéine précitée, et d'autre part l'utilisation d'un variant de CD14 dans le traitement ou la prévention d'un trouble de la voie gastro-intestinale chez un mammifère. Plus particulièrement, le trouble est compris dans le groupe constitué par les maladies intestinales inflammatoires, la maladie de Chrone, les colites ulcéreuses, les maladies coeliaques, la prolifération de bactéries intestinales, l'hépatite chronique, l'entérocolite nécrosante néonatale, la septicémie néonatale, les diarrhées infectieuses, le déséquilibre de la microflore intestinale, et les réactions allergiques dues au passage des aliments et des bactéries de l'intestin à d'autres parties du corps.
CA002347069A 1998-10-20 1999-10-15 Proteine pour le traitement ou la prevention d'un trouble de la voie gastro-intestinale Abandoned CA2347069A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98203501.6 1998-10-20
EP98203501 1998-10-20
PCT/EP1999/007911 WO2000022945A2 (fr) 1998-10-20 1999-10-15 Proteine pour le traitement ou la prevention d'un trouble de la voie gastro-intestinale

Publications (1)

Publication Number Publication Date
CA2347069A1 true CA2347069A1 (fr) 2000-04-27

Family

ID=8234231

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002347069A Abandoned CA2347069A1 (fr) 1998-10-20 1999-10-15 Proteine pour le traitement ou la prevention d'un trouble de la voie gastro-intestinale

Country Status (4)

Country Link
EP (1) EP1123011A2 (fr)
AU (1) AU6474099A (fr)
CA (1) CA2347069A1 (fr)
WO (1) WO2000022945A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2232273B1 (es) * 2003-03-21 2006-07-16 Jose Manuel Fernandez-Real Lemos Nuevas aplicaciones terapeuticas de la glucoproteina cd14s.
US20070036836A1 (en) 2003-06-23 2007-02-15 Magali Faure Amino acid supplementation for a healthy microbiota ecosystem
CA2583972A1 (fr) * 2004-10-14 2006-10-19 Adventures Plus Pty Ltd Methode pour le traitement de troubles gastro-intestinaux et d'autres troubles a l'aide d'un melange de vitamines et de mineraux
WO2009095916A2 (fr) * 2008-01-29 2009-08-06 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center Cd14 et peptides de celui-ci pour la protection de cellules contre la mort cellulaire
WO2014104305A1 (fr) * 2012-12-28 2014-07-03 持田製薬株式会社 Diagnostic de la maladie inflammatoire chronique de l'intestin par la mesure de la présepsine
WO2014152985A1 (fr) * 2013-03-14 2014-09-25 Children's Hospital Medical Center Biomarqueurs de l'entérocolite nécrosante avant terme

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4029227A1 (de) * 1990-09-14 1992-03-19 Imtox Gmbh Arzneimittel enthaltend cd14
US6093693A (en) * 1996-11-18 2000-07-25 The Wellesley Hospital Foundation B cell activation
CA2328134A1 (fr) * 1998-05-27 1999-12-02 Gemma Biotechnology Ltd. Induction de proteines et de peptides antibiotiques au moyen de la proteine scd14/lait

Also Published As

Publication number Publication date
EP1123011A2 (fr) 2001-08-16
AU6474099A (en) 2000-05-08
WO2000022945A2 (fr) 2000-04-27
WO2000022945A3 (fr) 2000-07-27

Similar Documents

Publication Publication Date Title
Kanwar et al. Molecular and biotechnological advances in milk proteins in relation to human health
Zimecki et al. Milk-derived proteins and peptides of potential therapeutic and nutritive value.
Martín-Sosa et al. Sialyloligosaccharides in human and bovine milk and in infant formulas: variations with the progression of lactation
O'Riordan et al. Structural and functional characteristics of bovine milk protein glycosylation
Schroten et al. Inhibition of adhesion of S-fimbriated Escherichia coli to buccal epithelial cells by human milk fat globule membrane components: a novel aspect of the protective function of mucins in the nonimmunoglobulin fraction
EP2046149B1 (fr) Formulations enrichies pour bébé
Kunz et al. Nutritional and biochemical properties of human milk, Part I: General aspects, proteins, and carbohydrates
Edde et al. Lactoferrin protects neonatal rats from gut-related systemic infection
Park Bioactive components in goat milk
US5505955A (en) Anti-diarrheic product and method of treating rotavirus-associated infection
Sienkiewicz et al. Supplementation of bovine colostrum in inflammatory bowel disease: benefits and contraindications
EP2661180B1 (fr) Composition contenant des protéines de lait thermolabiles et procédé de préparation associé
US20060246146A1 (en) Method of increasing the salivary sialic acid content in a mammal
Hatta et al. Bioactive components in egg yolk
US20200305488A1 (en) Human milk fortifier
US5888552A (en) Anti-cancer therapeutic compositions containing whey protein concentrate
Wang et al. Studies and application of sialylated milk components on regulating neonatal gut microbiota and health
CA2347069A1 (fr) Proteine pour le traitement ou la prevention d'un trouble de la voie gastro-intestinale
Jrad et al. Camel colostrum composition, nutritional value, and nutraceuticals
US20160106799A1 (en) Carbohydrate Compounds for Nutritional and Therapeutic Use
KR20140073591A (ko) 유아용 조제유
Miralles et al. Health-related functional value of dairy proteins and peptides
Guo et al. Chemistry and biological properties of human milk
JP2001226289A (ja) 肝機能改善剤
Fayed Healthy multifunctional spectra of milk glycoproteins and their fragments-a review article

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead